| Edward Andrew O'regan, MD | |
|
1531 Esplanade, Chico, CA 95926-3310 | |
| (530) 896-7455 | |
| (530) 896-1730 |
| Full Name | Edward Andrew O'regan |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 42 Years |
| Location | 1531 Esplanade, Chico, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972543379 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | A44337 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Enloe Medical Center | Chico, CA | Hospital |
| Oroville Hospital | Oroville, CA | Hospital |
| Orchard Hospital | Gridley, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Enloe Health And Wellness | 3678946282 | 6 |
| Enloe Medical Center | 9739092388 | 287 |
News Archive
Not all brain cancers are the same but together they represent a deadly disease that has been difficult to identify and treat. Scientists at multiple institutions have found a new way of classifying brain cancers that could very well change how the illness is diagnosed and treated.
Insulin resistance in the brain precedes and contributes to cognitive decline above and beyond other known causes of Alzheimer's disease, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania. Insulin is an important hormone in many bodily functions, including the health of brain cells.
Mazor Robotics Ltd., the leader in innovative surgical robots and complementary products for spine surgery, introduced today Renaissance, the next-generation of the world's only spinal robotic surgical guidance system.
Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.
A new UK study will provide better diagnoses for children with developmental disorders caused by changes in their genetic makeup. Scientists and clinicians will build a new national resource of genetic information and symptoms, based on data from 12,000 children who have a serious delay in their physical or mental development or are born with multiple malformations.
› Verified 7 days ago
| Entity Name | Enloe Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396753281 PECOS PAC ID: 9739092388 Enrollment ID: O20031110000404 |
News Archive
Not all brain cancers are the same but together they represent a deadly disease that has been difficult to identify and treat. Scientists at multiple institutions have found a new way of classifying brain cancers that could very well change how the illness is diagnosed and treated.
Insulin resistance in the brain precedes and contributes to cognitive decline above and beyond other known causes of Alzheimer's disease, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania. Insulin is an important hormone in many bodily functions, including the health of brain cells.
Mazor Robotics Ltd., the leader in innovative surgical robots and complementary products for spine surgery, introduced today Renaissance, the next-generation of the world's only spinal robotic surgical guidance system.
Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.
A new UK study will provide better diagnoses for children with developmental disorders caused by changes in their genetic makeup. Scientists and clinicians will build a new national resource of genetic information and symptoms, based on data from 12,000 children who have a serious delay in their physical or mental development or are born with multiple malformations.
› Verified 7 days ago
| Entity Name | Enloe Primary Physicians Medical Group A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205877156 PECOS PAC ID: 6305740929 Enrollment ID: O20031124000832 |
News Archive
Not all brain cancers are the same but together they represent a deadly disease that has been difficult to identify and treat. Scientists at multiple institutions have found a new way of classifying brain cancers that could very well change how the illness is diagnosed and treated.
Insulin resistance in the brain precedes and contributes to cognitive decline above and beyond other known causes of Alzheimer's disease, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania. Insulin is an important hormone in many bodily functions, including the health of brain cells.
Mazor Robotics Ltd., the leader in innovative surgical robots and complementary products for spine surgery, introduced today Renaissance, the next-generation of the world's only spinal robotic surgical guidance system.
Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.
A new UK study will provide better diagnoses for children with developmental disorders caused by changes in their genetic makeup. Scientists and clinicians will build a new national resource of genetic information and symptoms, based on data from 12,000 children who have a serious delay in their physical or mental development or are born with multiple malformations.
› Verified 7 days ago
| Entity Name | Enloe Health And Wellness |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740922426 PECOS PAC ID: 3678946282 Enrollment ID: O20230301002967 |
News Archive
Not all brain cancers are the same but together they represent a deadly disease that has been difficult to identify and treat. Scientists at multiple institutions have found a new way of classifying brain cancers that could very well change how the illness is diagnosed and treated.
Insulin resistance in the brain precedes and contributes to cognitive decline above and beyond other known causes of Alzheimer's disease, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania. Insulin is an important hormone in many bodily functions, including the health of brain cells.
Mazor Robotics Ltd., the leader in innovative surgical robots and complementary products for spine surgery, introduced today Renaissance, the next-generation of the world's only spinal robotic surgical guidance system.
Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.
A new UK study will provide better diagnoses for children with developmental disorders caused by changes in their genetic makeup. Scientists and clinicians will build a new national resource of genetic information and symptoms, based on data from 12,000 children who have a serious delay in their physical or mental development or are born with multiple malformations.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward Andrew O'regan, MD 1423 Magnolia Ave, Chico, CA 95926-3226 Ph: (530) 896-7455 | Edward Andrew O'regan, MD 1531 Esplanade, Chico, CA 95926-3310 Ph: (530) 896-7455 |
News Archive
Not all brain cancers are the same but together they represent a deadly disease that has been difficult to identify and treat. Scientists at multiple institutions have found a new way of classifying brain cancers that could very well change how the illness is diagnosed and treated.
Insulin resistance in the brain precedes and contributes to cognitive decline above and beyond other known causes of Alzheimer's disease, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania. Insulin is an important hormone in many bodily functions, including the health of brain cells.
Mazor Robotics Ltd., the leader in innovative surgical robots and complementary products for spine surgery, introduced today Renaissance, the next-generation of the world's only spinal robotic surgical guidance system.
Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.
A new UK study will provide better diagnoses for children with developmental disorders caused by changes in their genetic makeup. Scientists and clinicians will build a new national resource of genetic information and symptoms, based on data from 12,000 children who have a serious delay in their physical or mental development or are born with multiple malformations.
› Verified 7 days ago
Randall Slusarenko, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1531 Esplanade, Chico, CA 95926 Phone: 530-521-5061 | |
Nicholas Gaskill, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1531 Esplanade, Chico, CA 95926 Phone: 530-332-7300 | |
Dr. Frederick David Collins, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1531 Esplanade, Chico, CA 95926 Phone: 530-332-5335 Fax: 530-893-6885 | |
Sean Matthew Maiorano, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1423 Magnolia Ave, Chico, CA 95926 Phone: 530-896-7455 Fax: 530-896-1730 | |
Mehrdad Karimi, Hospitalist Medicare: Medicare Enrolled Practice Location: 1531 Esplanade, Chico, CA 95926 Phone: 530-896-7456 | |
Francisco Javier Alvarez, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1531 Esplanade, Chico, CA 95926 Phone: 530-896-7455 Fax: 530-896-1730 | |
Mrs. Aurelia Veronica Silvestri, FNP-BC Hospitalist Medicare: Medicare Enrolled Practice Location: 1270 Dog Leg Dr, Chico, CA 95928 Phone: 530-720-6973 Fax: 530-879-0120 |